EGFR and prostate carcinoma: To clarify whether the EGFR is a risk factor for prostate cancer, this study aimed to determine whether a causal relationship exists between the two variables using Mendelian randomization (MR), which is a powerful analytical method for identifying causal relationships between risk factors and diseases, with genetic variability as an instrumental variable.